Erendor, F. Et Al. 2019. LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes. ESGCT 27th Annual Congress in collaboration with SETGyc Meeting , (Barcelona, Spain).

Erendor, F., Sahin, E. O., BALCI, M. K., & Sanlioglu, S., (2019). LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes . ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, Spain

Erendor, FULYA Et Al. "LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes," ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, Spain, 2019

Erendor, FULYA E. Et Al. "LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes." ESGCT 27th Annual Congress in collaboration with SETGyc Meeting , Barcelona, Spain, 2019

Erendor, F. Et Al. (2019) . "LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes." ESGCT 27th Annual Congress in collaboration with SETGyc Meeting , Barcelona, Spain.

@conferencepaper{conferencepaper, author={FULYA ERENDOR CİHAN Et Al. }, title={LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes}, congress name={ESGCT 27th Annual Congress in collaboration with SETGyc Meeting}, city={Barcelona}, country={Spain}, year={2019}}